ethopropazine
Trade name: parsidol
Small moleculeapproved
Ethopropazine is an anticholinergic drug. Ethopropazine is an inhibitor of butyrylcholinesterase and non-selective muscarinic acetylcholine receptor antagonist. Ethopropazine has been used for the treatment of parkinsonism and drug-induced extrapyramidal reactions. Also It used for the symptomatic treatment of hepatolenticular degeneration and congenital athetosis. — NCATS
Clinical trial activity
0 trials · 0 clinical orgs · 2 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
1950s
- Jun 1, 1953
Rhone Poulenc — First NDA Organization
- Jun 1, 1953
Rhone Poulenc — NDA Organization
Indications
Mechanism of action
- Muscarinic acetylcholine receptor M1ANTAGONIST
CHRM1 antagonist
Indicated for Parkinson's disease, M1 likely responsible
Approval history
- approved—
Chemistry & pharmacology
Loading structure…
SMILES
CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21- Mol. weight
- 312.48 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
- Delivery
- Oral
- Availability
- Discontinued
Oral
Yes
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1206 ↗
- WikipediaProfenamine ↗
- NCATS7WI4P02YN1 ↗
- ChEMBLCHEMBL310555 ↗
- ChEMBLCHEMBL1697698 ↗
- ChEMBLCHEMBL1200970 ↗
Also known as
- 10-[2-(diethylamino)-1-propyl]phenothiazine
- 10-[2-(diethylamino)-1-propyl]phenothiazine
- 10-[2-(diethylamino)-2-methylethyl]phenothiazine
- 10-[2-(diethylamino)-2-methylethyl]phenothiazine
- 10-(2-diethylaminopropyl)phenothiazine
- 10-(2-diethylaminopropyl)phenothiazine
- 10-[2-(diethylamino)propyl]phenothiazine
- 10-[2-(diethylamino)propyl]phenothiazine
- 10h-phenothiazine-10-ethanamine, n,n-diethyl-alpha-methyl-
- 2-diethylamino-1-propyl-n-dibenzoparathiazine
- 2-diethylamino-1-propyl-n-dibenzoparathiazine
- ethapropazine
- ethopromazine
- ethopropazine
- ethopropazine
- ethopropazine
- ethopropazine
- ethopropazine
- ethopropazine
- ethopropazine
- ethopropazine
- ethopropazine hcl
- ethopropazine hcl
- ethopropazine hcl
- ethopropazine hydrochloride
- ethopropazine hydrochloride
- ethopropazine hydrochloride
- ethopropazine hydrochloride
- ethopropazine hydrochloride
- isopthazine
- isothazine
- isothiazine
- lysivane
- n,n-diethyl-1-(10h-phenothiazin-10-yl)-2-propanamine
- n,n-diethyl-1-(10h-phenothiazin-10-yl)-2-propanamine
- n,n-diethyl-alpha-methyl-10h-phenothiazine-10-ethanamine
- n,n-diethyl-alpha-methyl-10h-phenothiazine-10-ethanamine
- parsidol
- parsidol
- parsidol
- parsidol
- parsitan
- profenamina
- profenamina
- profenamine
- profenamine
- profenamine
- profenamine
- profenamine
- profenamine
- profenamine hcl
- profenamine hcl
- profenamine hibenzate
- profenamine hibenzate
- profenamine hibenzate
- profenamine hibenzate
- profenamine hibenzate
- profenamine hydrochloride
- profenamine hydrochloride
- profenaminum
- profenaminum
- prophenamine hcl
- prophenamine hcl
Organizations
Marketing (2)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Parke-Davis | For profit | NDA2 | — |
| Rhone Poulenc | For profit | NDA | Jun 1, 1953 |